Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span
- PMID: 30877180
- PMCID: PMC6785795
- DOI: 10.2967/jnumed.118.224113
Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span
Abstract
Measuring early tau accumulation is important in studying aging and Alzheimer disease and is only as accurate as the signal-to-noise ratio of the tracer. Along with aggregated tau in the form of neurofibrillary tangles, 18F-flortaucipir has been reported to bind to neuromelanin, monoamine oxidase, calcifications, iron, leptomeningeal melanocytes, and microhemorrages. Although 18F-flortaucipir successfully differentiates healthy controls (HCs) from subjects with Alzheimer disease, variability exists in the cortical signal in amyloid-negative HCs. We aimed to explore the relationship between off-target binding signal and variability in the cortical signal in HCs. Methods: Subjects (n = 139) received 11C-Pittsburgh compound B (PIB) and 18F-flortaucipir PET scans and a magnetization-prepared rapid gradient echo MRI scan. PET frames were realigned and coregistered to the MR images, which were segmented using FreeSurfer. In amyloid-negative HCs (n = 90; age range, 21-94 y), 7 nonspecific or off-target binding regions were considered: caudate, pallidum, putamen, thalamus, cerebellar white matter, hemispheric white matter, and choroid plexus. These regions of interest were assigned to 3 similarly behaving groups using principle components analysis, exploratory factor analysis, and Pearson correlations for caudate, putamen, and pallidum (also correlated with age); thalamus and white matter; and choroid plexus. In amyloid-negative HCs with 11C-PIB and 18F-flortaucipir scans, correlations were calculated between white and gray matter before and after partial-volume correction. Results: The correlation between white and gray matter disappeared after partial-volume correction in 11C-PIB (r2 = 0) but persisted for 18F-flortaucipir (r2 = 0.27), demonstrating that the correlation between white and gray matter signal in 18F-flortaucipir is not solely due to partial-volume effects. A linear regression showed that off-target signal from putamen and thalamus together explained 64% of the variability in the cortical signal in amyloid-negative HCs (not seen in amyloid-positive HCs). Variability in amyloid-negative HCs but not amyloid-positive HCs correlated with white matter signal (unrelated to partial-volume effects) and age-related off-target signal (possibly related to iron load). Conclusion: The noise in the 18F-flortaucipir measurement could pose challenges when studying early tau accumulation.
Keywords: 18F-flortaucipir PET; off-target binding; tau.
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Figures




Similar articles
-
Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.J Nucl Med. 2018 Jun;59(6):937-943. doi: 10.2967/jnumed.117.200691. Epub 2017 Dec 28. J Nucl Med. 2018. PMID: 29284675
-
Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity.J Nucl Med. 2018 Jun;59(6):944-951. doi: 10.2967/jnumed.117.200006. Epub 2017 Nov 30. J Nucl Med. 2018. PMID: 29191858
-
Compensating for choroid plexus based off-target signal in the hippocampus using 18F-flortaucipir PET.Neuroimage. 2020 Nov 1;221:117193. doi: 10.1016/j.neuroimage.2020.117193. Epub 2020 Jul 22. Neuroimage. 2020. PMID: 32711062
-
Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework.Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2097-2109. doi: 10.1007/s00259-020-05118-w. Epub 2021 Feb 6. Eur J Nucl Med Mol Imaging. 2021. PMID: 33547556 Free PMC article. Review.
-
Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.J Mov Disord. 2018 Jan;11(1):1-12. doi: 10.14802/jmd.17071. Epub 2018 Jan 23. J Mov Disord. 2018. PMID: 29381890 Free PMC article. Review.
Cited by
-
The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions.J Nucl Med. 2023 Mar;64(3):452-459. doi: 10.2967/jnumed.122.264434. Epub 2022 Nov 17. J Nucl Med. 2023. PMID: 36396455 Free PMC article.
-
Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease.J Cereb Blood Flow Metab. 2023 Jun;43(6):921-936. doi: 10.1177/0271678X231152001. Epub 2023 Jan 25. J Cereb Blood Flow Metab. 2023. PMID: 36695071 Free PMC article.
-
What's the cut-point?: a systematic investigation of tau PET thresholding methods.Alzheimers Res Ther. 2022 Apr 5;14(1):49. doi: 10.1186/s13195-022-00986-w. Alzheimers Res Ther. 2022. PMID: 35382866 Free PMC article. Review.
-
Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans.Proc Natl Acad Sci U S A. 2021 Sep 7;118(36):e2025000118. doi: 10.1073/pnas.2025000118. Proc Natl Acad Sci U S A. 2021. PMID: 34479997 Free PMC article.
-
Evaluation of [18F]-JNJ-64326067-AAA tau PET tracer in humans.J Cereb Blood Flow Metab. 2021 Dec;41(12):3302-3313. doi: 10.1177/0271678X211031035. Epub 2021 Jul 14. J Cereb Blood Flow Metab. 2021. PMID: 34259071 Free PMC article. Clinical Trial.
References
-
- Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl). 1991;82:239–259. - PubMed
-
- Chien DT, Bahri S, Szardenings AK, et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis. 2013;34:457–468. - PubMed
-
- Xia CF, Arteaga J, Chen G, et al. [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease. Alzheimers Dement. 2013;9:666–676. - PubMed